Medic Vision Ltd., a company specializing in imaging solutions dedicated to the enhancement of medical images, announced today that it will be unveiling its SafeCT™ product at the Annual Meeting of the Radiological Society of North America. Based on GiRR3D (Generic iterative Retro Reconstruction in 3D™), the company’s proprietary patented iterative image reconstruction algorithms, SafeCT, dramatically enhances the SNR (Signal-to-Noise Ratio) of low-dose CT images generated by conventional CT scanners, providing an unsurpassed potential for more than 50% reduction in the exam dose with the same diagnostic quality.
The SafeCT has been clinically validated at leading medical centers in Israel, with hundreds of patients tested and clinical results presented in a number of papers presented at the American Society of Neuroradiology (ASNR) in May 2010. Further beta-site clinical validation is currently underway in the USA at University of Pittsburgh Medical Center.
Besides its capability to substantially reduce radiation dose, SafeCT has the ability to preserve image detail and image look.
For more information, visit www.medicvision.com